Full-Time

Director – Gxp Quality Assurance and Compliance

Confirmed live in the last 24 hours

Schrödinger

Schrödinger

501-1,000 employees

Computational platform for biopharmaceutical research

Government & Public Sector
Enterprise Software
Biotechnology

Compensation Overview

$185k - $235kAnnually

Senior, Expert

Cambridge, MA, USA + 1 more

More locations: New York, NY, USA

New York is home to our largest office.

Category
QA & Testing
Quality Assurance
Required Skills
Google Cloud Platform
Requirements
  • Bachelor's degree in life sciences (Master’s degree in life sciences preferred)
  • Twelve to fifteen years of Quality Assurance experience in the pharmaceutical or biotech industry, with at least five years in a leadership role
  • Technical quality experience preferred
  • Experience in manufacturing operations preferred
  • Expert level knowledge of GMP regulations and FDA requirements, Guidance documents, and industry best practices, with a focus on Analytical/QC testing
  • Good working knowledge of global GxP standards, including USP/Ph., FDA/EMA, and ICH
  • History of success with the management of inspections performed by the FDA and other regulatory bodies
  • Excellent written and oral communication skills
  • Ability to travel domestically and internationally on occasion
Responsibilities
  • Design, develop and implement overall GxP Quality Assurance strategy and vision for Schrödinger’s Therapeutics Group
  • Develop, implement, and manage the continuous improvement of robust quality management systems, including, *e.g.*, vendor management, deviation management, change control, CAPAs, product label review, risk management, and eQMS (MasterControl)
  • Ensure compliance, in collaboration with relevant SMEs and senior leaders, with all applicable GxP regulations, including GMP, GCP, and GLP
  • Establish key quality system metrics and process indicators to proactively identify and address quality systems or product issues
  • Oversee the development and implementation of all relevant training programs to ensure staff are knowledgeable about GxP requirements and quality standards
  • Provide leadership and guidance to teams on inspection readiness, including hosting and participating in regulatory inspections (GMP, BIMO, etc.)
  • Account for appropriate oversight of all vendors, including CDMOs and CROs, to ensure regulatory compliance
  • Serve as spokesperson and technical subject matter quality expert for all matters governed by GMP-related regulations/guidelines and industry best practices (*e.g.*, FDA, EMA, PMDA, etc.)
  • Perform and manage day-to-day GMP QA activities
  • Author, review, and approve all relevant GMP quality documents

Schrödinger provides a computational platform that aids in the research efforts of biopharmaceutical companies, academic institutions, and government laboratories around the world. Their platform offers advanced computational tools that help in drug discovery and research across various therapeutic areas. Schrödinger's products work by utilizing sophisticated algorithms and simulations to predict molecular behavior, which assists researchers in understanding how different compounds can affect biological systems. What sets Schrödinger apart from its competitors is its extensive global reach, serving clients in over 70 countries, and its dual focus on both software licensing and collaborative drug discovery programs. The company's goal is to advance scientific research and innovation by providing powerful tools and services that enhance the drug discovery process.

Company Stage

IPO

Total Funding

$362.7M

Headquarters

New York City, New York

Founded

1990

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • $19.5M Gates Foundation grant boosts research in neglected diseases, expanding R&D opportunities.
  • $10M grant supports predictive toxicology tools, reducing drug development failures.
  • Schrödinger's platform efficiently explores chemical space, accelerating drug candidate identification.

What critics are saying

  • Recursion and Exscientia merger creates a strong competitor in AI-driven drug discovery.
  • Avicenna's independent expansion could lead to competitive tensions with Schrödinger.
  • Reliance on grants like Gates Foundation funding poses financial sustainability risks.

What makes Schrödinger unique

  • Schrödinger's platform supports diverse clients, including biopharmaceuticals and academic institutions globally.
  • The company excels in rapid drug discovery, exemplified by SGR-1505's swift development.
  • Schrödinger's collaboration with Avicenna enhances medicinal chemistry through machine learning.

Help us improve and share your feedback! Did you find this helpful?